ZIRGAN® (ganciclovir ophthalmic gel) 0.15%: Official HCP Website
Learn about Bausch + Lomb's ZIRGAN® gel, a topical ophthalmic antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Find MOA, dosing information, prescription savings & more.
ZIRGAN® Dosing Schedule And Handling Instructions
ZIRGAN ® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Important Safety Information. ZIRGAN ® is indicated for topical ophthalmic use only.
ZIRGAN (ganciclovir ophthalmic gel) 0.15% is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). 2 DOSAGE AND ADMINISTRATION The recommended dosing regimen for ZIRGAN is 1 drop in the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals, and then
About ZIRGAN® | HSV Ocular Diseases - zirganpro.com
ZIRGAN ® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). Important Safety Information. ZIRGAN ® is indicated for topical ophthalmic use only.
ZIRGAN® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).
How ZIRGAN® Works: Mechanism Of Action - zirganpro.com
Witness how ZIRGAN® targets HSV-infected cells with a video of its MOA and learn why ZIRGAN® 's formulation is key to its effectiveness. Please see risks and benefits.
Save On ZIRGAN® With The Bausch + Lomb Access Program
Download the Bausch + Lomb Access Program Card to help your patients save on ZIRGAN® prescriptions. Request samples and formulary information. See benefits and risks.
ZIRGAN® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers). IMPORTANT SAFETY INFORMATION
Please see full Prescribing Information for ZIRGAN on pages 5 and 6. HERPES SIMPLEX VIRUS DENDRITIC EPITHELIAL KERATITIS: DIAGNOSIS AND MANAGEMENT antiviral agents selectively inhibit viral DNA synthesis in
ZIRGAN® Insurance Coverage | Formulary Lookup Tool
Find out if your paitent is covered by insurance in 3 quick steps with the Formulary Lookup Tool. Find the brand status of your patient and any coverage restrictions. Please see benefits and risks of using ZIRGAN® .